The Cancer Biomarkers Research Group promotes research to identify, develop, and validate biological markers for early cancer detection and cancer risk assessment. Activities include development and validation of promising cancer biomarkers, collaborative databases and informatics systems, and new technologies or the refinement of existing technologies.
Read more About the Cancer Biomarkers Research Group.
Alliance of Pancreatic Cancer Consortia, and the European Liquid Biopsy Society Workshop on Extracellular Vesicles in Early Detection of Pancreatic Cancer meeting
This meeting will be held virtually via Zoom on Thursday, May 25 from 8:00 a.m. - 2:30 p.m. ET and Friday, May 26 from 8:00 a.m. - 12:30 p.m. ET. Registration is required.
News and Events
Could A Diabetes Diagnosis Help Detect Pancreatic Cancer Early?
Date Posted: July 7, 2021
The Search for Early Detection of Pancreatic Cancer Accelerates with Biomarkers
Date Posted: April 27, 2021
Taking Advantage of the Transportation Processes from Inside to Outside the Cell to Detect Cancer
Date Posted: December 11, 2019
New Onset Diabetes Cohort Sought to Unravel Complexities of Pancreatic Cancer Development
Date Posted: November 19, 2019